GP

Gyan Prakash Mittal

Active Director Director DIN 06831857
DIN 06831857 First appointment Mar 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value •••• Premium profile

About Gyan Prakash Mittal

Data last updated:

Gyan Prakash Mittal is a Director at Nilyam Pharmaceuticals Private Limited (since 2014). The company operates in Trading. Nilyam Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2017).

DIN 06831857
Primary Designation Director
Industry Trading
First Appointment 05 Mar 2014
Oldest Company Age 14 yrs
Largest company Nilyam Pharmaceuticals Private Limited · ₹3.9 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Mar 20142012₹3.9 Lakh (FY 2017)Active

Board colleagues of Gyan Prakash Mittal

Directorship timeline

Open interactive timeline →
Nilyam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gyan Prakash Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gyan Prakash Mittal

Gyan Prakash Mittal currently holds 1 directorship: Nilyam Pharmaceuticals Private Limited (Director, since 05 Mar 2014, revenue ₹3.9 Lakh (FY 2017)).

Gyan Prakash Mittal was first appointed on 05 Mar 2014 as Director at Nilyam Pharmaceuticals Private Limited.

The current boards of Gyan Prakash Mittal's companies include Beena Rani (Nilyam Pharmaceuticals Private Limited), Mohit Kumar Mittal (Nilyam Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available